When a child looks unusually pale, feels constantly tired, or struggles with unexplained weakness, parents naturally worry. While many conditions can cause such symptoms, one important diagnosis to consider is megaloblastic anaemia-a condition where the body produces abnormally large, immature red blood cells. In children, this condition most commonly stems from deficiencies in two essential vitamins: folic acid (vitamin B9) and vitamin B12. Understanding its causes, recognizing its symptoms early, and knowing how healthcare providers manage it can make a significant difference in a child’s recovery and long-term health.
Table of Contents
- What is megaloblastic anaemia?
- Primary causes in children
- Folic acid deficiency
- Vitamin B12 deficiency
- Recognizing the symptoms
- General symptoms of anaemia
- Distinctive clinical features
- Neurological manifestations
- Diagnostic approach
- Blood tests and peripheral smear
- Bone marrow examination
- Additional investigations
- Management strategies
- Folic acid supplementation
- Vitamin B12 replacement
- Critical importance of neurological monitoring
- Prevention and follow-up care
What is megaloblastic anaemia?
Megaloblastic anaemia is a blood disorder characterized by the presence of unusually large red blood cells that are not fully developed. In healthy individuals, red blood cells are disc-shaped and carry oxygen efficiently throughout the body. However, in megaloblastic anaemia, the bone marrow produces fewer cells, and those that are formed often have an oval shape rather than the normal round appearance. These malformed cells may also have a shorter lifespan than the typical 120 days, further reducing the body’s oxygen-carrying capacity.
The underlying problem lies in impaired DNA synthesis within red blood cell precursors. Both vitamin B12 and folic acid serve as essential building blocks for DNA production. When these vitamins are deficient, cell division in the bone marrow becomes disrupted, leading to the characteristic large, immature cells.
Primary causes in children
While megaloblastic anaemia can occur at any age, its causes in children often differ from those in adults. Understanding these causes helps healthcare providers tailor their diagnostic approach and treatment strategies.
Folic acid deficiency
Folic acid is critical for producing normal red blood cells and supporting rapid cell division during growth. In children, deficiency can occur due to inadequate dietary intake, particularly in families following restrictive diets or those with limited access to fresh vegetables and fruits. Conditions affecting the digestive tract, such as celiac disease, chronic infectious enteritis, and enteroenteric fistulas, can impair folic acid absorption. Additionally, certain medications, especially those used to prevent seizures like phenytoin, primidone, and phenobarbital, can interfere with how the body absorbs folic acid.
Some infants are born with inherited congenital folate malabsorption-a rare genetic condition where the intestines cannot properly absorb folic acid. This condition requires early intensive treatment to prevent serious long-term complications, including intellectual disabilities.
Vitamin B12 deficiency
Vitamin B12 deficiency in infants and young children often results from maternal deficiency during pregnancy and breastfeeding. Mothers following strict vegetarian or vegan diets without adequate supplementation may have low B12 stores, which affects both their breast milk content and their infant’s vitamin reserves at birth. The deficiency typically manifests between 2 and 12 months of age in exclusively breastfed infants.
Other causes include pernicious anaemia, where the body cannot produce intrinsic factor-a protein made in the stomach that is essential for B12 absorption. Although rare in children, this condition can occur. Previous surgeries involving the stomach or intestines, as well as various digestive diseases affecting absorption, can also lead to B12 deficiency in pediatric patients.
Recognizing the symptoms
The symptoms of megaloblastic anaemia develop gradually and may initially be subtle, making early recognition challenging. However, being aware of the key signs can prompt timely medical evaluation.
General symptoms of anaemia
Children with megaloblastic anaemia commonly experience fatigue, weakness, and decreased energy levels. Pallor or abnormal paleness of the skin is often noticeable, along with decreased appetite and irritability. Some children may have shortness of breath during physical activity, dizziness, or heart palpitations as the body struggles to deliver adequate oxygen to tissues.
Distinctive clinical features
Glossitis is a hallmark symptom that presents as a smooth, red, tender tongue-often described as having a “beefy” appearance. The tongue loses its normal texture due to the absence of filiform papillae. Oral ulcers and angular stomatitis (cracks at the corners of the mouth) may also occur. These oral manifestations result from the rapid turnover of cells in the mouth being affected by impaired DNA synthesis.
Hyperpigmentation is another characteristic finding that parents and clinicians should watch for. Darkening of the skin and mucous membranes can occur, particularly on the dorsal surfaces of fingers and toes, as well as in the creases of palms and soles. The distribution is typically patchy. This hyperpigmentation gradually resolves after weeks to months of appropriate vitamin treatment.
Bleeding tendency may develop in more severe cases because megaloblastic anaemia can affect platelet production, leading to thrombocytopenia. Children may bruise easily or have prolonged bleeding from minor cuts.
Neurological manifestations
Vitamin B12 deficiency can cause significant neurological symptoms that may appear even before anaemia becomes evident. In infants, these include hypotonia (decreased muscle tone), developmental regression, lethargy, and failure to thrive. Older children may experience numbness and tingling in the hands and feet, difficulty walking, balance problems, and cognitive changes including memory difficulties and confusion.
Approximately half of infants with B12 deficiency exhibit abnormal movements such as tremors, twitches, or myoclonus. These movements may appear before treatment begins and typically disappear within one or two days after starting vitamin supplementation. Interestingly, some children may develop movement disorders a few days after treatment starts, even as other neurological symptoms improve-these usually resolve within two to six weeks.
Diagnostic approach
Diagnosing megaloblastic anaemia involves a systematic evaluation combining clinical assessment, detailed history-taking, and laboratory investigations.
Blood tests and peripheral smear
The complete blood count (CBC) reveals low haemoglobin levels and an elevated mean corpuscular volume (MCV), indicating macrocytic red blood cells. A peripheral blood smear examination allows healthcare providers to visualize the abnormally large, oval-shaped red blood cells under a microscope. Hypersegmented neutrophils-white blood cells with more than five nuclear lobes-are another characteristic finding that supports the diagnosis.
Serum vitamin B12 and folate levels help identify the specific deficiency. Additional tests such as methylmalonic acid and homocysteine levels can provide further confirmation, as both are elevated in B12 deficiency while only homocysteine is elevated in isolated folate deficiency.
Bone marrow examination
In some cases, bone marrow aspiration may be performed to confirm the diagnosis. The bone marrow shows megaloblastic changes characterized by large erythroid precursors with immature nuclei but relatively mature cytoplasm-a finding described as nuclear-cytoplasmic asynchrony. This examination helps rule out other causes of macrocytic anaemia.
Additional investigations
If an absorption problem is suspected, investigations to evaluate the digestive tract may be necessary. These can include tests for celiac disease, assessment of intrinsic factor antibodies, or imaging studies of the gastrointestinal system.
Management strategies
Treatment of megaloblastic anaemia focuses on correcting the underlying vitamin deficiency and addressing any contributing conditions. The approach varies depending on whether the deficiency involves folic acid, vitamin B12, or both.
Folic acid supplementation
For folate deficiency, oral folic acid supplements are the primary treatment. The typical course involves daily supplementation for at least two to three months. Foods rich in folic acid-including dark green leafy vegetables, oranges, beans, lentils, and fortified cereals-should be incorporated into the child’s diet for long-term maintenance.
Vitamin B12 replacement
Vitamin B12 deficiency often requires intramuscular injections because oral absorption may be compromised. Injections are given frequently initially-often daily or weekly-then transitioned to monthly maintenance doses. In cases where absorption issues are permanent, such as pernicious anaemia, lifelong supplementation is necessary.
Dietary adjustments should include foods rich in B12, such as meat, fish, eggs, dairy products, and fortified cereals. For families following vegetarian or vegan diets, careful supplementation planning with healthcare guidance is essential.
Critical importance of neurological monitoring
One crucial aspect of managing megaloblastic anaemia is monitoring for neurological symptoms, particularly during treatment. While most children show rapid improvement in their general condition within weeks of starting vitamin supplementation, neurological symptoms require careful observation.
An important clinical consideration is that folic acid supplementation alone can mask an underlying B12 deficiency by improving the haematological picture while allowing neurological damage to progress. For this reason, B12 levels should always be checked before starting folic acid treatment, and both vitamins should be supplemented if dual deficiency is suspected.
The long-term prognosis depends significantly on the duration of deficiency and severity of symptoms at diagnosis. Infants diagnosed and treated before one year of age generally have more favourable neurological outcomes than those treated later. Early treatment prevents progression of neurological damage and, in many cases, allows complete recovery. However, prolonged deficiency can cause lasting neurodevelopmental effects, underscoring the importance of prompt diagnosis and treatment.
Prevention and follow-up care
Preventing megaloblastic anaemia involves ensuring adequate vitamin intake, particularly for high-risk groups. Pregnant and breastfeeding mothers following vegetarian or vegan diets should receive appropriate supplementation to protect their infants. Children on restrictive diets require careful nutritional monitoring and supplementation as needed.
After treatment, follow-up blood tests confirm that vitamin levels have normalized and the anaemia has resolved. Ongoing dietary counselling helps families maintain adequate nutrition and prevent recurrence. For children with absorption disorders or inherited conditions, long-term management plans ensure continued vitamin adequacy.
What do you think? Have you encountered challenges in ensuring adequate vitamin B12 and folic acid intake for children in your care? What strategies have you found most effective for managing dietary deficiencies in pediatric patients?
References
- https://www.chop.edu/conditions-diseases/megaloblastic-anemia
- https://rarediseases.org/rare-diseases/anemia-megaloblastic/
- https://www.stanfordchildrens.org/en/topic/default?id=megaloblastic-anemia-in-children-90-P02325
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6884369/
- https://www.childrensnational.org/get-care/health-library/anemia-megaloblastic-or-pernicious
- https://www.childrenshospital.org/conditions/megaloblastic-anemia
- https://emedicine.medscape.com/article/200184-clinical
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8140678/
- https://pubmed.ncbi.nlm.nih.gov/18708898/
- https://my.clevelandclinic.org/health/diseases/23160-megaloblastic-anemia
- https://www.ncbi.nlm.nih.gov/books/NBK535377/
- https://www.nationwidechildrens.org/conditions/health-library/megaloblastic-anemia-in-children
- https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-0804-x
Leave a Reply